Electronic Resource

Characterization of a novel HDAC2 pathogenetic variant: a missing puzzle piece for chromatinopathies

التفاصيل البيبلوغرافية
العنوان: Characterization of a novel HDAC2 pathogenetic variant: a missing puzzle piece for chromatinopathies
المؤلفون: Di Fede, E, Lettieri, A, Taci, E, Castiglioni, S, Rebellato, S, Parodi, C, Colombo, E, Grazioli, P, Natacci, F, Marchisio, P, Pezzani, L, Fazio, G, Milani, D, Massa, V, Gervasini, C, Di Fede E., Lettieri A., Taci E., Castiglioni S., Rebellato S., Parodi C., Colombo E. A., Grazioli P., Natacci F., Marchisio P., Pezzani L., Fazio G., Milani D., Massa V., Gervasini C.
بيانات النشر: Springer country:DE 2024
نوع الوثيقة: Electronic Resource
مستخلص: Histone deacetylases (HDACs) are enzymes pivotal for histone modification (i.e. acetylation marks removal), chromatin accessibility and gene expression regulation. Class I HDACs (including HDAC1, 2, 3, 8) are ubiquitously expressed and they often participate in multi-molecular protein complexes. To date, three neurodevelopmental disorders caused by mutations in genes encoding for HDACs (HDAC4, HDAC6 and HDAC8) and thus belonging to the group of chromatinopathies, have been described. We performed whole exome sequencing (WES) for a patient (#249) clinically diagnosed with the chromatinopathy Rubinstein-Taybi syndrome (RSTS) but negative for mutations in RSTS genes, identifying a de novo frameshift variant in HDAC2 gene. We then investigated its molecular effects in lymphoblastoid cell lines (LCLs) derived from the patient compared to LCLs from healthy donors (HD). As the variant was predicted to be likely pathogenetic and to affect the sequence of nuclear localization signal, we performed immunocytochemistry and lysates fractionation, observing a nuclear mis-localization of HDAC2 compared to HD LCLs. In addition, HDAC2 total protein abundance resulted altered in patient, and we found that newly identified variant in HDAC2 affects also acetylation levels, with significant difference in acetylation pattern among patient #249, HD and RSTS cells and in expression of a known molecular target. Remarkably, RNA-seq performed on #249, HD and RSTS cells shows differentially expressed genes (DEGs) common to #249 and RSTS. Interestingly, our reported patient was clinically diagnosed with RSTS, a chromatinopathy which known causative genes encode for enzymes antagonizing HDACs. These results support the role of HDAC2 as causative gene for chromatinopathies, strengthening the genotype-phenotype correlations in this relevant group of disorders.
مصطلحات الفهرس: HDAC2, chromatinopathies, variant, info:eu-repo/semantics/article
URL: https://hdl.handle.net/10281/495900
info:eu-repo/semantics/altIdentifier/pmid/38753158
info:eu-repo/semantics/altIdentifier/wos/WOS:001226727900001
volume:143
issue:6
firstpage:747
lastpage:759
numberofpages:13
journal:HUMAN GENETICS
الاتاحة: Open access content. Open access content
ملاحظة: STAMPA
English
Other Numbers: ITBAO oai:boa.unimib.it:10281/495900
10.1007/s00439-024-02675-0
info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85193480415
1456740600
المصدر المساهم: BICOCCA OPEN ARCH
From OAIster®, provided by the OCLC Cooperative.
رقم الانضمام: edsoai.on1456740600
قاعدة البيانات: OAIster